JANE STREET GROUP, LLC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 116 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2016$75,000
+36.4%
14,050
+32.2%
0.00%
Q4 2015$55,000
-46.6%
10,625
-37.8%
0.00%
-100.0%
Q3 2015$103,000
-97.1%
17,084
-92.4%
0.00%
-95.7%
Q2 2015$3,560,000
-29.4%
225,441
-51.4%
0.02%
-41.0%
Q1 2015$5,042,000
+3580.3%
463,811
+3472.4%
0.04%
+3800.0%
Q4 2014$137,000
-84.9%
12,983
-86.3%
0.00%
-88.9%
Q3 2014$910,000
-79.5%
94,936
-75.3%
0.01%
-84.2%
Q2 2014$4,446,000
+3268.2%
384,904
+2807.1%
0.06%
+5600.0%
Q1 2014$132,00013,2400.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2016
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders